000			01947 a2200553 4500
005			20250517171731.0
264		0	_c20170920
008			201709s 0 0 eng d
022			_a1538-3598
024	7		_a10.1001/jama.2017.11467 _2doi
040			_aNLM _beng _cNLM
100	1		_aFerence, Brian A
245	0	0	_aAssociation of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk. _h[electronic resource]
260			_bJAMA _c09 2017
300			_a947-956 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnticholesteremic Agents _xtherapeutic use
650	0	4	_aApolipoproteins B _xblood
650	0	4	_aCardiovascular Diseases _xgenetics
650	0	4	_aCholesterol Ester Transfer Proteins _xantagonists & inhibitors
650	0	4	_aCholesterol, HDL _xblood
650	0	4	_aCholesterol, LDL _xblood
650	0	4	_aFemale
650	0	4	_aGenetic Variation
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl CoA Reductases _xgenetics
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use
650	0	4	_aHypercholesterolemia _xblood
650	0	4	_aMale
650	0	4	_aMendelian Randomization Analysis
650	0	4	_aMiddle Aged
650	0	4	_aRisk Factors
700	1		_aKastelein, John J P
700	1		_aGinsberg, Henry N
700	1		_aChapman, M John
700	1		_aNicholls, Stephen J
700	1		_aRay, Kausik K
700	1		_aPackard, Chris J
700	1		_aLaufs, Ulrich
700	1		_aBrook, Robert D
700	1		_aOliver-Williams, Clare
700	1		_aButterworth, Adam S
700	1		_aDanesh, John
700	1		_aSmith, George Davey
700	1		_aCatapano, Alberico L
700	1		_aSabatine, Marc S
773	0		_tJAMA _gvol. 318 _gno. 10 _gp. 947-956
856	4	0	_uhttps://doi.org/10.1001/jama.2017.11467 _zAvailable from publisher's website
999			_c27502895 _d27502895